La industria farmacéutica socava su futuro mientras impide el acceso de millones de personas a medicamentos básicos

La industria farmacéutica niega el acceso a medicamentos básicos a millones de personas y socava su propio futuro, debido a la negativa de las compañías a cambiar sus estrategias de negocio en los mercados de los países en vías de desarrollo, según alerta Oxfam Internacional...El informe "Invertir en la vida. Cómo lograr el acceso a medicamentos esenciales a través de prácticas empresariales responsables" pone la lupa en las 12 principales compañías farmacéuticas mundiales. [se refiere a Abbott, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis y Wyeth]

타임라인

Response by Sanofi-Aventis: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

날짜:

2008년 2월 12일

내용 유형:

기업 응답

이용 가능한 언어: English
Wyeth (part of Pfizer) did not respond to: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

날짜:

2007년 12월 19일

내용 유형:

기업 응답

이용 가능한 언어: English
Response by Johnson & Johnson: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

날짜:

2007년 12월 18일

내용 유형:

기업 응답

이용 가능한 언어: English
Response by Abbott Laboratories: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

날짜:

2007년 12월 18일

내용 유형:

기업 응답

이용 가능한 언어: English
Response by Merck: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices"

날짜:

2007년 12월 12일

내용 유형:

기업 응답

이용 가능한 언어: English
Response by Novartis: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

날짜:

2007년 12월 12일

내용 유형:

기업 응답

이용 가능한 언어: English
Response by AstraZeneca: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

날짜:

2007년 12월 12일

내용 유형:

기업 응답

이용 가능한 언어: English
Eli Lilly did not respond to: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

날짜:

2007년 12월 12일

내용 유형:

기업 응답

이용 가능한 언어: English
Response by Pfizer: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

날짜:

2007년 12월 12일

내용 유형:

기업 응답

이용 가능한 언어: English
Bristol-Myers Squibb did not respond to: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

날짜:

2007년 12월 12일

내용 유형:

기업 응답

이용 가능한 언어: English
Roche did not respond to: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

날짜:

2007년 12월 12일

내용 유형:

기업 응답

이용 가능한 언어: English
Oxfam report "Investing for Life": Company responses

날짜:

2007년 12월 12일

내용 유형:

기사

이용 가능한 언어: English
La industria farmacéutica socava su futuro mientras impide el acceso de millones de personas a medicamentos básicos

날짜:

2007년 11월 27일

내용 유형:

기사

이용 가능한 언어: español
Oxfam says top drug companies focusing on patents, not poor

날짜:

2007년 11월 26일

내용 유형:

기사

이용 가능한 언어: English
L’industrie pharmaceutique met en péril son propre avenir en empêchant des millions de personnes pauvres d’avoir accès aux médicaments

날짜:

2007년 11월 23일

내용 유형:

기사

이용 가능한 언어: français
Response by GlaxoSmithKline: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

날짜:

2007년 11월 12일

내용 유형:

기업 응답

이용 가능한 언어: English
[PDF] Investing for life - Meeting poor people’s needs for access to medicines through responsible business practices

날짜:

2007년 11월 1일

내용 유형:

기사

이용 가능한 언어: English

전체 스토리 보기

더 보기 덜 보기

Business & Human Rights
Resource Centre

구속력 있는 조약

실사 의무화

공동번영의 모색: 정의로운 전환을 위한 원주민 리더십과 파트너십

Switched off: 테크기업의 투명성 부족과 가자지구에서의 이스라엘-하마스 전쟁

기업과인권리소스센터

구속력 있는 조약

실사 의무화

공동번영의 모색: 정의로운 전환을 위한 원주민 리더십과 파트너십

Switched off: 테크기업의 투명성 부족과 가자지구에서의 이스라엘-하마스 전쟁

이 페이지는 한국어로 제공되지 않으며 Spanish로 표시됩니다.

La industria farmacéutica socava su futuro mientras impide el acceso de millones de personas a medicamentos básicos

타임라인

Response by Sanofi-Aventis: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

Wyeth (part of Pfizer) did not respond to: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

Response by Johnson & Johnson: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

Response by Abbott Laboratories: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

Response by Merck: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices"

Response by Novartis: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

Response by AstraZeneca: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

Eli Lilly did not respond to: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

Response by Pfizer: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

Bristol-Myers Squibb did not respond to: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

Roche did not respond to: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

Oxfam report "Investing for Life": Company responses

La industria farmacéutica socava su futuro mientras impide el acceso de millones de personas a medicamentos básicos

Oxfam says top drug companies focusing on patents, not poor

L’industrie pharmaceutique met en péril son propre avenir en empêchant des millions de personnes pauvres d’avoir accès aux médicaments

Response by GlaxoSmithKline: Oxfam report "Investing for Life" says drug companies not doing enough to provide access to medicines for the poor - makes recommendations for "responsible business practices".

[PDF] Investing for life - Meeting poor people’s needs for access to medicines through responsible business practices